Where does Neurometrix, Inc. rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), Neurometrix, Inc. ranks #7,596 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does Neurometrix, Inc. hold?

Neurometrix, Inc. holds 43 US utility patents granted between 2015 and 2025, spanning 4 technology areas.

What is Neurometrix, Inc.'s Innovation Score?

Neurometrix, Inc. has an Innovation Score of 39.3 out of 100 (top 38% of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

What technology areas does Neurometrix, Inc. focus on?

Neurometrix, Inc.'s top technology area is A61N (ELECTROTHERAPY; MAGNETOTHERAPY; Radiation THERAPY; Ultrasound Therapy) with 29 patents, ranking #132 of 1,943 assignees active in that subclass. Grants appear in 4 CPC subclasses total.

Is Neurometrix, Inc.'s patent grant rate increasing or decreasing?

Neurometrix, Inc.'s recent grant velocity is -36% compared to the prior five-year period (grant years, not application filing dates). Grant activity has slowed relative to earlier years.

What does claim depth mean for Neurometrix, Inc.'s patents?

Neurometrix, Inc.'s patents average 27.1 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the Neurometrix, Inc. patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView US Corporation

Neurometrix, Inc.

USPTO PatentsView assignee record - 43 granted patents across 4 technology areas, recorded in grant years 2015–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61N (ELECTROTHERAPY; MAGNETOTHERAPY; Radiation THERAPY; Ultrasound Therapy).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Neurometrix ranks #7,596 of 49,997 tracked US assignees by granted-patent volume, with 43 patents across 4 technology areas.

#7,596
of 49,997 US assignees by volume: Top 38%
by Innovation Score (39.3/100): 27.1
avg claims per patent: -36%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R7596 · US Corporation #7,596 · 43 grants

GRANTS-SMALL · UPPER-Q · PHOTO-FINISH · CPC-NARROW · INNOV-THIN · CLAIMS-DENSE · TYPE-USCORP · VEL-DOWN · BOOK-FULL

GRANTS-SMALL 43 grants
UPPER-Q #7,596/49,997
PHOTO-FINISH Mimosa Networks
CPC-NARROW A61N · 4 areas
INNOV-THIN 39.3/100
CLAIMS-DENSE 27.1 claims/avg
TYPE-USCORP US Corporation
VEL-DOWN -36% vel
BOOK-FULL 10/10 fields

Nearest grant-volume peer: Mimosa Networks, Inc. (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Neurometrix’s 39.3 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Volume 13.1 pts (33%) Velocity 4.2 pts (11%) Breadth 7.1 pts (18%) Claim depth 15.0 pts (38%)

Qualcomm Incorporated · highest

85
ADC Czech Republic… · near

39
Dongbu HiTek · near

39
Neurometrix · this assignee

39
Oceus Networks · near

39
Thinkspan · near

39
3D Lighting… · lowest

7

What this shows Neurometrix's Innovation Score is 39.3/100 (top 38% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Does more volume mean deeper claims for Neurometrix?

Each dot is one of Neurometrix’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Neurometrix’s own 27.1 claims/patent is ABOVE the 16.9 median for these volume peers. More thorough claims than most filers at this scale, not just more of them.

Neurometrix vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Neurometrix's grants concentrate

Neurometrix, Inc. is a focused PatentsView assignee: 4 CPC subclasses with 67.4% of grants classified under A61N (ELECTROTHERAPY; MAGNETOTHERAPY; Radiation THERAPY; Ultrasound Therapy). Peak complete grant year is 2019 (10 grants) versus a trough of 1 in 2016. By volume, Neurometrix sits between Mimosa Networks, Inc. and Novira Therapeutics, Inc..

Neurometrix's three-year grant acceleration

Neurometrix, Inc. shows 10 grants in 2022–2024 against only 16 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.

Mimosa Networks

43
Myscript

43
Nabtesco Automoti…

43
National Universi…

43
Nok Nok Labs

43
Nokia Siemens Net…

43
Norgren

43
Novira Therapeuti…

43
Neurometrix ◀

43

What this shows Neurometrix holds 43 patents at rank #7,596, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Neurometrix

By rank, the assignees closest to #7,596 in granted patent volume.

Leaders in A61N (Electrotherapy)

Other assignees with the most granted patents in Neurometrix's primary technology class.

Assignees with similar portfolio profiles

Two PlainPatent-derived peer sets for Neurometrix, neither rank-band nor same-CPC leaders (those blocks stay above). In A61N (Electrotherapy), Neurometrix ranks #132 of 1,943 assignees by patent count in that subclass.

Similar innovation score

Nearest assignees by Innovation Score (39 here).

Oceus Networks, LLC 39 ADC Czech Republic s.r.o. 39 Dongbu HiTek Co., Ltd. 39 Thinkspan, LLC 39

Neurometrix's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

39 Top 38% higher than 62% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2015–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.

View data table

Neurometrix, Inc. patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2015	6	14.0%
2016	1	2.3%
2017	4	9.3%
2018	4	9.3%
2019	10	23.3%
2020	2	4.7%
2021	4	9.3%
2022	6	14.0%
2023	2	4.7%
2024	2	4.7%
2025partial year	2	4.7%

Which technologies does Neurometrix, Inc. patent most?

A61N - ELECTROTHERAPY; MAGNETOTHERAPY; Radiation THERAPY; Ultrasound Therapy 29

A61B - DIAGNOSIS; SURGERY; Identification 21

G06F - Electric Digital Data Processing 5

Y02D - Climate Change Mitigation Technologies IN Information AND Communication Technologies [ICT], I.E. Information AND Communication Technologies Aiming AT THE Reduction OF Their OWN Energy USE 2

Top 4 of 4 technology areas

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

View all rankings → How is Innovation Score calculated?

What to do with this data

Neurometrix, Inc.'s patent record in context - here's where to go next.

Neurometrix, Inc.'s lead technology class is A61N (ELECTROTHERAPY; MAGNETOTHERAPY; Radiation THERAPY; Ultrasound Therapy), 67.4% of its portfolio - see every assignee active in that class. Explore A61N
Ranked #7,596 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare Neurometrix, Inc. against Mimosa Networks, Inc., an assignee filing at a similar volume. Compare portfolios
Innovation Score of 39.3/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent, US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.